Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | natriuretic peptide receptor 2 | Starlite/ChEMBL | References |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 0.28 nM | Inhibitory activity against non-guanylate cyclase receptor binding site in rabbit lung by using [125I]-ANP-(103-126) | ChEMBL. | 2564895 |
IC50 (binding) | > 100 nM | Inhibitory activity against guanylate cyclase coupled receptor binding site in rabbit lung by using [125I]-ANP-(103-126) | ChEMBL. | 2564895 |
IC50 (binding) | > 100 nM | Inhibitory activity against guanylate cyclase coupled receptor binding site in rabbit lung by using [125I]-ANP-(103-126) | ChEMBL. | 2564895 |
Ratio (binding) | > 357 | Ratio of IC50 of guanylate cyclase coupled receptor binding and non-guanylate cyclase coupled binding | ChEMBL. | 2564895 |
Relative affinity (binding) | < 0.003 | Relative affinity for guanylate cyclase coupled binding site in rabbit lung, by using [125I]-ANP-(103-126) as a standard (giving an arbitrary value of 1.0) | ChEMBL. | 2564895 |
Relative affinity (binding) | = 0.5 | Relative affinity for non-guanylate cyclase coupled binding site in rabbit lung, by using [125I]-ANP-(103-126) as a standard (giving an arbitrary value of 1.0) | ChEMBL. | 2564895 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.